GC Therapeutics

Biotechnology Research • Cambridge, Massachusetts, United States • 21-50 Employees

Company overview

Headquarters	Cambridge, Massachusetts, United States
Website	gc-tx.com
NAICS	541714
SIC	154
Employees	21-50
Socials

Key Contacts at GC Therapeutics

Parastoo Khoshakhlagh

Ceo & Co-Founder

Houssam Alosta

Director Process Development

Alex Hmng

Co-Founder And Chief Scientific Officer

Alexandra Rich

Director Of Finance Operations

GC Therapeutics Email Formats

GC Therapeutics uses 2 email formats. The most common is {first initial} (e.g., j@gc-tx.com), used 50% of the time.

Format	Example	Percentage
{first initial}	j@gc-tx.com	50%
{first name}	john@gc-tx.com	50%

About GC Therapeutics

GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases. The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.

GC Therapeutics revenue & valuation

Annual revenue	$3,678,865
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$11,800,000
Total funding	$65,339,900